Harmonized Index of Consumer Prices: Pharmaceutical Products for Sweden
CP0611SEM086NEST • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
105.14
Year-over-Year Change
0.10%
Date Range
1/1/1999 - 6/1/2025
Summary
The Harmonized Index of Consumer Prices for Pharmaceutical Products in Sweden measures changes in the prices of drugs and medicines purchased by consumers. This key economic indicator helps policymakers and analysts track inflationary pressures in the Swedish healthcare sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products in Sweden provides a standardized measure of consumer price inflation for pharmaceutical goods. It is a component of the broader HICP, which is a widely-used metric for monitoring price stability across the European Union.
Methodology
The data is collected through regular surveys of consumer prices by Statistics Sweden, the national statistical agency.
Historical Context
The HICP for Pharmaceutical Products is closely watched by the Swedish central bank and other economic institutions as an input to monetary policy decisions.
Key Facts
- The HICP for Pharmaceutical Products in Sweden has a base year of 2015.
- Sweden's pharmaceutical sector accounts for over 10% of total healthcare spending.
- The index is published monthly by Eurostat, the European Union's statistical agency.
FAQs
Q: What does this economic trend measure?
A: The Harmonized Index of Consumer Prices for Pharmaceutical Products in Sweden measures changes in the prices paid by consumers for drugs and medicines.
Q: Why is this trend relevant for users or analysts?
A: This index is an important indicator of inflationary pressures in the Swedish healthcare sector, which is closely monitored by policymakers and economists.
Q: How is this data collected or calculated?
A: The data is collected through regular consumer price surveys conducted by Statistics Sweden, the national statistical agency.
Q: How is this trend used in economic policy?
A: The HICP for Pharmaceutical Products is used by the Swedish central bank and other institutions as an input to monetary policy decisions aimed at maintaining price stability.
Q: Are there update delays or limitations?
A: The index is published monthly by Eurostat with no significant update delays, providing timely data to analysts and policymakers.
Related Trends
Production, Sales, Work Started and Orders: Production Volume: Economic Activity: Industry (Except Construction) for Sweden
PRINTO01SEQ661N
Labor Compensation: Earnings: Manufacturing: Hourly for Sweden
LCEAMN01SEM657S
Total Credit to Households and Non-Profit Institutions Serving Households, Adjusted for Breaks, for Sweden
CRDQSEAHABIS
Harmonized Index of Consumer Prices: Overall Index Excluding Education, Health, and Social Protection for Sweden
00XEDUSEM086NEST
Harmonized Index of Consumer Prices: Passenger Transport by Road for Sweden
CP0732SEM086NEST
Interest Rates: 3-Month or 90-Day Rates and Yields: Interbank Rates: Total for Sweden
IR3TIB01SEM156N
Citation
U.S. Federal Reserve, Harmonized Index of Consumer Prices: Pharmaceutical Products for Sweden (CP0611SEM086NEST), retrieved from FRED.